(Q41657513)

English

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial

scientific article published on 19 December 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

hypertrophic cardiomyopathy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Morten S Jensen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Henning Bundgaard

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Anna Axelsson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Niels Vejlstrup

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Carolyn Ho

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jakob Norsk

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Lasse Langhoff

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Kiril Ahtarovski

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Pernille Corell

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ole Havndrup

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

123-131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Shared genetic causes of cardiac hypertrophy in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan decreases type I collagen synthesis in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an Angiotensin II receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

NT-ProBNP: the mechanism behind the marker

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970241-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(14)70241-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25533774%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41657513&oldid=1925632066"